Navigation Links
Dr. M. Fatih Yanik joins Intellimedix
Date:6/12/2013

ATLANTA, June 12, 2013 /PRNewswire-iReach/ -- Dr. M. Fatih Yanik has recently joined the team at Intellimedix and will oversee the company's new technology development efforts. Dr. Yanik is an associate professor in the Electrical Engineering department of MIT and heads the school's High-Throughput Neurotechnology Group. In 2011, he was awarded the most prestigious NIH award, the NIH Director's Pioneer Award, and is the youngest recipient in the history of this award. Dr. Yanik is also the first person ever to receive all of the top NIH awards:  the NIH Director's New Innovator Award, the NIH EUREKA Award, the NIH Transformative Research Award, and the NIH Director's Pioneer Award.

"Fatih Yanik is a pioneer in the development of technologies for regenerative neurobiology and development of innovative drug discovery models and platforms. Additionally, Dr. Yanik and his research team have developed a novel and groundbreaking method of creating induced pluripotent stem cells (iPSCs) using RNA-based technology that holds great promise for personalized neurobiology. Fatih brings a treasure trove of talent to Intellimedix," says Dr. Jeffrey Skolnick, Chief Scientist at Intellimedix.

"Intellimedix has a very dedicated and world-class team who is truly passionate about finding cures for epilepsy and other neurological disorders. I am truly excited to join them in this endeavor as we set out to improve the quality of life for many people," says Dr. Yanik.

Dr. Yanik will play a major role in developing novel technologies and guiding the research at Intellimedix's Cambridge, MA based lab.

About IntelliMedix:

IntelliMedix was founded in early 2012 with the purpose of developing and applying novel technologies to accelerate the discovery of new therapies for neurological diseases and creating new approaches for personalized medicine. They employ cutting-edge technology that includes gene sequencing, in silico screening, optogenetics, synthetic biology, and high-throughput in vivo and in vitro models. The company's current focus is on developing new treatments for Dravet Syndrome and other types of intractable epilepsy. For more information, please visit http://www.intellimedix.com

Media Contact:

Joanna Morrison Intellimedix, 770.399.9930, jmorrison@intellimedix.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE IntelliMedix
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Nutrilys Del Mar Joins Health Forces With LAPD Underwater Dive Unit
2. Keith McCormick Joins Trovagene, Inc. as Head of Commercial Operations
3. Aethlon Medical Note: Marc Robins Joins the Aethlon Team
4. Effie Toshav Joins Fenwick - Broadens Life Sciences Service Platform
5. David F. Harty Joins Systech International as Vice President
6. Jim DuCharme Joins Prime Therapeutics as Chief Financial Officer
7. Ted Pacha Joins Pinnaclife as President of its Healthcare Distribution Division
8. Rittal Corp. Joins the HP ProActive Insight Architecture Alliance
9. Anthony Creed Joins DDSTUDIO As GM, Experience Design
10. IntelliCell Announces Dr. Arnold I. Caplan Joins Scientific Advisory Board
11. American Society of Hematology joins European Hematology Association, Patient Groups in Issuing International Call to Action to Alleviate Drug Shortages
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Ill. , June 23, 2016  In a startling report ... are failing their residents by lacking a comprehensive, proven plan to ... a definitive ranking of how states are tackling the worst ... to only four states – Kentucky , ... Vermont . Of the 28 failing states, three ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Key Pharma News Issue 52" report to their offering. ... need in influenza treatment creates a favourable commercial environment for ... and growing patient base that will serve to drive considerable ... flu vaccine would serve to cap sales considerably, but development ...
(Date:6/23/2016)... , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate ... in Latin America . ... ... ... ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health ... of their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards ... at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and ... that call for a minimum wage raise to $12 an hour by 2020 and then ... will restore the lost value of the minimum wage, assure the wage floor does not ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, ... economy by obtaining investment capital for emerging technology companies. SCP has delivered ... already resulted in more than a million dollars of capital investment for five ...
Breaking Medicine News(10 mins):